Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

573 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of Low-Dose Aspirin Versus Placebo on Incidence of Anemia in the Elderly : A Secondary Analysis of the Aspirin in Reducing Events in the Elderly Trial.
McQuilten ZK, Thao LTP, Pasricha SR, Artz AS, Bailey M, Chan AT, Cohen HJ, Lockery JE, Murray AM, Nelson MR, Schneider HG, Wolfe R, Woods RL, Wood EM, McNeil JJ. McQuilten ZK, et al. Among authors: nelson mr. Ann Intern Med. 2023 Jul;176(7):913-921. doi: 10.7326/M23-0675. Epub 2023 Jun 20. Ann Intern Med. 2023. PMID: 37335992 Clinical Trial.
Rationale for a trial of low-dose aspirin for the primary prevention of major adverse cardiovascular events and vascular dementia in the elderly: Aspirin in Reducing Events in the Elderly (ASPREE).
Nelson M, Reid C, Beilin L, Donnan G, Johnston C, Krum H, Storey E, Tonkin A, McNeil J; Aspirin in Reducing Events in the Elderly (ASPREE) Study Group,. Nelson M, et al. Drugs Aging. 2003;20(12):897-903. doi: 10.2165/00002512-200320120-00004. Drugs Aging. 2003. PMID: 14565783 Clinical Trial.
Age-related macular degeneration in a randomized controlled trial of low-dose aspirin: Rationale and study design of the ASPREE-AMD study.
Robman L, Guymer R, Woods R, Ward S, Wolfe R, Phung J, Hodgson L, Makeyeva G, Aung KZ, Gilbert T, Lockery J, Le-Pham YA, Orchard S, Storey E, Abhayaratna W, Reid D, Ernst ME, Nelson M, Reid C, McNeil J. Robman L, et al. Contemp Clin Trials Commun. 2017 Jun;6:105-114. doi: 10.1016/j.conctc.2017.03.005. Epub 2017 Mar 27. Contemp Clin Trials Commun. 2017. PMID: 28736754 Free PMC article.
Prognostic Value of a Polygenic Risk Score for Coronary Heart Disease in Individuals Aged 70 Years and Older.
Neumann JT, Riaz M, Bakshi A, Polekhina G, Thao LTP, Nelson MR, Woods RL, Abraham G, Inouye M, Reid CM, Tonkin AM, McNeil J, Lacaze P. Neumann JT, et al. Among authors: nelson mr. Circ Genom Precis Med. 2022 Feb;15(1):e003429. doi: 10.1161/CIRCGEN.121.003429. Epub 2021 Dec 24. Circ Genom Precis Med. 2022. PMID: 34949098 Free PMC article. Clinical Trial.
Safety of Ceasing Aspirin Used Without a Clinical Indication After Age 70 Years: A Subgroup Analysis of the ASPREE Randomized Trial.
Nelson MR, Polekhina G, Woods RL, Reid CM, Tonkin AM, Wolfe R, Murray AM, Kirpach B, Ernst ME, Lockery JE, Shah RC, Stocks N, Orchard SG, Zhou Z. Nelson MR, et al. Ann Intern Med. 2022 May;175(5):761-764. doi: 10.7326/M21-3823. Epub 2022 Mar 15. Ann Intern Med. 2022. PMID: 35286146 Free PMC article. Clinical Trial. No abstract available.
Prediction of disability-free survival in healthy older people.
Neumann JT, Thao LTP, Murray AM, Callander E, Carr PR, Nelson MR, Wolfe R, Woods RL, Reid CM, Shah RC, Newman AB, Williamson JD, Tonkin AM, McNeil JJ; ASPREE investigators. Neumann JT, et al. Among authors: nelson mr. Geroscience. 2022 Jun;44(3):1641-1655. doi: 10.1007/s11357-022-00547-x. Epub 2022 Apr 14. Geroscience. 2022. PMID: 35420334 Free PMC article. Clinical Trial.
573 results